A nasal antibody cocktail binding to the conserved S2 stalk region of SARS-COV-2 might end the corona...
Up To Date
Latest News
This new investment will support the growth of the Mourenx site and sustain the growing demand for production...
Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build...
BioInvent has successfully carried out a directed share issue of approximately SEK 300 million (approximately...
Immunocore sells around 3.7m shares in a private placement with a 20% discount and gets USD140m to advance its...